HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME: Take the course for this article: Volume 67, Number 2, July 25, 2006 Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Siddiqi, Z. A. Articles by Massey, J. M. Search for Related Content PubMed PubMed Citation Articles by Siddiqi, Z. A. Articles by Massey, J. M. Related Collections Metabolic disease (inherited) Lipidoses All Clinical trials Clinical trials Observational study (Cohort, Case control) Related Articles

Peripheral neuropathy in Krabbe disease

Effect of hematopoietic stem cell transplantation

From the Divisions of Neurology, University of Alberta Hospital (Z.A.S.), Edmonton, AB, Canada, and Duke University Medical Center (D.B.S., J.M.M.), Durham, NC.

Address correspondence and reprint requests to Dr Siddiqi, Division of Neurology, 2E3.11, University of Alberta Hospital, Edmonton, AB, Canada T6G 2B7; e-mail: zsiddiqi{at}ualberta.ca

Background: Hematopoietic stem cell transplantation (HSCT) may slow the progression of Krabbe disease (KD) if performed early in the disease. The authors' studies indicate that more than 90% of patients with KD have severe abnormalities in peripheral nerve conduction.

Objective: To assess the effect of HSCT on nerve conduction in patients with KD.

Methods: The authors performed serial nerve conduction studies (NCS) in 12 patients with KD after HSCT. The average follow-up was 18 months (6 months to 3 years) after HSCT. Pretransplant NCS were not available in two patients; all others (10 of 12) had significant pretransplant abnormalities.

Results: After HSCT, previously absent F-waves (1 patient) and sural sensory responses (SNR) (3 patients) were found recordable. All patients continued to have recordable SNR after HSCT, and these became normal in 7 of 12 patients. Distal motor nerve latency became normal in 6 of 17 and motor nerve conduction velocity (CV) in 2 of 17 nerves; F-wave latencies (FWL) improved in 6 of 17 nerves, but did not become normal in any. There was greater improvement in nerve conduction abnormalities if the transplant was performed earlier in life. After an initial improvement, there was subsequent worsening of motor latencies (2 of 12), motor CV (2 of 12), FWL (3 of 12), and SSR (1 of 12), indicating that benefit from HSCT may be temporary.

Conclusions: Serial nerve conduction studies are useful in following the course of peripheral neuropathy in Krabbe disease. Hematopoietic stem cell transplantation is followed by improvement in peripheral nerve conduction abnormalities in these patients, suggesting remyelination of the nerves.

Editorial, see page 201

See also page 263

Disclosure: The authors report no conflicts of interest.

Received December 1, 2005. Accepted in final form April 26, 2006.

Related Articles

Peripheral nerve involvement in Krabbe disease: A guide to therapy selection and evaluation

Hugo W. Moser
Neurology 2006 67: 201-202. [Full Text] [PDF]

This article has been cited by other articles:

				H. W. Moser Peripheral nerve involvement in Krabbe disease: a guide to therapy selection and evaluation. Neurology, July 25, 2006; 67(2): 201 - 202. [Full Text] [PDF]